1. Home
  2. EVAX vs UGRO Comparison

EVAX vs UGRO Comparison

Compare EVAX & UGRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVAX
  • UGRO
  • Stock Information
  • Founded
  • EVAX 2008
  • UGRO 2014
  • Country
  • EVAX Denmark
  • UGRO United States
  • Employees
  • EVAX N/A
  • UGRO N/A
  • Industry
  • EVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • UGRO Industrial Specialties
  • Sector
  • EVAX Health Care
  • UGRO Consumer Discretionary
  • Exchange
  • EVAX Nasdaq
  • UGRO Nasdaq
  • Market Cap
  • EVAX 8.7M
  • UGRO 8.8M
  • IPO Year
  • EVAX 2021
  • UGRO N/A
  • Fundamental
  • Price
  • EVAX $2.49
  • UGRO $0.73
  • Analyst Decision
  • EVAX Strong Buy
  • UGRO Strong Buy
  • Analyst Count
  • EVAX 3
  • UGRO 2
  • Target Price
  • EVAX $33.33
  • UGRO $5.63
  • AVG Volume (30 Days)
  • EVAX 6.9M
  • UGRO 130.2K
  • Earning Date
  • EVAX 03-26-2025
  • UGRO 03-26-2025
  • Dividend Yield
  • EVAX N/A
  • UGRO N/A
  • EPS Growth
  • EVAX N/A
  • UGRO N/A
  • EPS
  • EVAX N/A
  • UGRO N/A
  • Revenue
  • EVAX $3,295,000.00
  • UGRO $70,320,066.00
  • Revenue This Year
  • EVAX $9,039.73
  • UGRO $17.15
  • Revenue Next Year
  • EVAX $1.47
  • UGRO $21.76
  • P/E Ratio
  • EVAX N/A
  • UGRO N/A
  • Revenue Growth
  • EVAX N/A
  • UGRO 12.08
  • 52 Week Low
  • EVAX $2.22
  • UGRO $0.60
  • 52 Week High
  • EVAX $22.50
  • UGRO $2.84
  • Technical
  • Relative Strength Index (RSI)
  • EVAX 39.85
  • UGRO 36.76
  • Support Level
  • EVAX $2.30
  • UGRO $0.66
  • Resistance Level
  • EVAX $2.80
  • UGRO $1.12
  • Average True Range (ATR)
  • EVAX 0.51
  • UGRO 0.12
  • MACD
  • EVAX 0.03
  • UGRO 0.01
  • Stochastic Oscillator
  • EVAX 6.97
  • UGRO 25.05

About EVAX Evaxion Biotech

Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.

About UGRO urban-gro Inc.

Urban-gro Inc is an integrated professional services and construction design-build firm. Its business focuses predominantly on providing fee-based knowledge-based services as well as the value-added reselling of equipment. The company offers value-added architectural, engineering, systems procurement and integration, and construction design-build solutions to customers operating in the controlled environment agriculture (CEA) and industrial and other commercial (Commercial) sectors. It derives revenue predominately from the sale of equipment systems, services, construction design-build, and other various immaterial contracts with customers.

Share on Social Networks: